Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 171.85m |
Free float | 170.04m |
P/E (TTM) | -- |
Market cap | 12.88bn USD |
EPS (TTM) | -5.40 USD |
Data delayed at least 15 minutes.
More ▼
Press releases
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update
- Insmed to Host Second-Quarter 2024 Financial Results Conference Call on Thursday, August 8, 2024
- Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
- Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025
More ▼